ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Osteoarthritis"

  • Abstract Number: 0213 • ACR Convergence 2021

    Quantitative Assessment of Volumetric Change in Hip Effusion Using Artificial Intelligence in Patients with Osteoarthritis of the Hip

    Jacob Jaremko1, Banafshe Felfeliyan2, Abhilash Hareendranathan1, Bashiar Thejeel1, Vanessa Quinn-Laurin1, Mikkel Ostergaard3, Philip Conaghan4, Robert Lambert1, Janet Ronsky2 and Walter Maksymowych1, 1University of Alberta, Edmonton, AB, Canada, 2University of Calgary, Calgary, AB, Canada, 3Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, and Department of Clinical Medicine, University of Copenhagen, Glostrup, Denmark, 4Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom

    Background/Purpose: Accurate quantification of hip effusion volume may aid effective OA management as synovitis of the hip has been associated with pain and structural damage…
  • Abstract Number: 0482 • ACR Convergence 2021

    Metformin Use Reduces the Risk of Developing Osteoarthritis: A Propensity Score Matching Study

    Khushboo Sheth1, Di Lu2, Rong Lu2, William Robinson3 and Matthew Baker4, 1Stanford University/VA Palo Alto, Atherton, CA, 2Stanford University, Stanford, 3Stanford University, Palo Alto, CA, 4Stanford University, Menlo Park, CA

    Background/Purpose: Preclinical and observational data suggest a protective effect of metformin against developing osteoarthritis (OA).1,2 In this retrospective cohort study, we evaluated the time to…
  • Abstract Number: 0735 • ACR Convergence 2021

    Walking Ability 12 Months After Total Knee Arthroplasty for Osteoarthritis – Gap Between Expectations and Reality: The BEST Knee Cohort Study

    Lauren King, Esther Waugh and Gillian Hawker, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Improved ability to walk is a key driver for people with knee osteoarthritis (OA) to seek total knee arthroplasty (TKA). However, the extent to…
  • Abstract Number: 1057 • ACR Convergence 2021

    Impact of Osteoarthritis in Younger Adults

    Elizabeth Badley1, Jessica Wilfong2 and Anthony Perruccio1, 1Schroeder Arthritis Institute, University Health Network, Toronto, ON, Canada, 2Shcroeder Arthritis Institute, University Health Network, Toronto, ON, Canada

    Background/Purpose: OA is a disease frequently perceived as a disease of the elderly and an inevitable result of aging. Consequently, epidemiological and clinical studies of…
  • Abstract Number: 1130 • ACR Convergence 2021

    Osteoarthritis Patients Feel Their Tissue Remodeling

    Anne-Christine Bay-Jensen1, Yi He2, Christian Thudium1 and Morten Karsdal3, 1Nordic Bioscience, Herlev, Denmark, 2Nordic Bioscience A/S, Herlev, Denmark, 3Nordic Bioscience, Herlev

    Background/Purpose: Osteoarthritis (OA) is a chronic disease characterized by pain and disability. Central to the revised FDA guidelines for the approval of a disease modifying…
  • Abstract Number: 1478 • ACR Convergence 2021

    An Orphan Receptor and Osteoarthritis: Mouse Gpr34 Expression in Dorsal Root Ganglia After Partial Meniscectomy

    David Thomas1, Terese Geraghty2, Alia Obeidat2, Jun Li2, Rachel Miller2 and Anne-Marie Malfait3, 1University of Minnesota Internal Medicine Residency, St. Paul, MN, 2Rush University Medical Center, Chicago, IL, 3Rush University, Chicago, IL

    Background/Purpose: Osteoarthritis (OA) is one of the leading causes of musculoskeletal pain and disability. Worldwide, an estimated 303 million patients have clinically diagnosed OA, with…
  • Abstract Number: 0214 • ACR Convergence 2021

    Baseline Cam or Pincer Morphology Is Associated with Loss of Quantitative Joint Space Width at the Hip: The Johnston County Osteoarthritis Project

    Amanda Nelson1, Carolina Alvarez1, Yvonne Golightly1, Jamie Stiller2, Jordan Renner1, Nigel Arden3, Charles Ratzlaff4 and Jeffrey Duryea5, 1University of North Carolina at Chapel Hill, Chapel Hill, NC, 2Alamance Regional Medical Center, Durham, NC, 3University of Oxford, Oxford, United Kingdom, 4University of British Columbia, Vancouver, BC, Canada, 5Brigham and Women's Hospital, Boston, MA

    Background/Purpose: To determine the association between radiographic cam and pincer morphology and loss of hip quantitative joint space width (qJSW) in a community-based cohort.Methods: Data…
  • Abstract Number: 0483 • ACR Convergence 2021

    Frequent Use of Prescription Oral NSAIDs Among People with Knee or Hip Osteoarthritis Despite Contraindications to or Precautions with NSAIDs

    Tuhina Neogi1, Andrea Dell'isola2, Martin Englund2 and Aleksandra Turkiewicz2, 1Boston University School of Medicine, Boston, MA, 2Lund University, Lund, Sweden

    Background/Purpose: Oral NSAIDs are recommended for OA management. However, many patients with OA have contraindications to NSAIDs or have comorbidities that warrant precaution. Because few…
  • Abstract Number: 0736 • ACR Convergence 2021

    Decrease in Prevalence of Self-Reported Anxiety or Depression in Persons with Osteoarthritis After Total Knee Arthroplasty: The BEST KNEE Cohort Study

    Owen Krystia, Lauren King, Esther Waugh and Gillian Hawker, University of Toronto, Toronto, ON, Canada

    Background/Purpose: While anxiety and depression are highly prevalent in persons with symptomatic knee osteoarthritis (OA), few studies have assessed the effect of treatment of knee…
  • Abstract Number: 1058 • ACR Convergence 2021

    Sex-Specific Associations Between Knee Synovial Fluid Biomarkers and Knee Osteoarthritis Pain

    Anthony Perruccio, Elizabeth Badley, J Denise Power, Mayilee Canizares, Nizar Mahomed, Kahlid Syed, Rajiv Gandhi, J. Roderick Davey, Mohit Kapoor, Christian Veillette and Y Raja Rampersaud, Schroeder Arthritis Institute, University Health Network, Toronto, ON, Canada

    Background/Purpose: Sex has received limited attention in osteoarthritis (OA) clinical studies assessing relationships between biomarkers and pain. In prior work we reported sex-specific associations between…
  • Abstract Number: 1131 • ACR Convergence 2021

    Interleukin 6 Concentration in Synovial Fluid and Its Clinical Significance

    Ivars Veckalns and Anna Mihailova, Riga Stradins University, Riga, Latvia

    Background/Purpose: Inflammatory arthritis (IA) treated with disease modifying antirheumatic drugs lead to secondary osteoarthritis (OA) due to inflammation, aging, and other factors. Inflammatory arthritis can…
  • Abstract Number: 1479 • ACR Convergence 2021

    CD14, a Toll-like Receptor Co-Factor, Influences Osteoclast Differentiation and Activity, but Does Not Alter Osteoblastic Potential of Bone-Marrow Precursors in Mice

    Jerahme Martinez, Vu Nguyen, Cheng Zhou, George Dodge and Carla Scanzello, University of Pennsylvania, philadelphia, PA

    Background/Purpose: Changes in subchondral bone structure (SCB) occur in osteoarthritis (OA), and are visible by imaging as subchondral sclerosis on radiographs, and bone marrow lesions…
  • Abstract Number: 0215 • ACR Convergence 2021

    Ultrasonographic Assessment of Knee Osteoarthritis and Its Agreement with Radiography

    Khoa Nguyen1 and Duc Tran2, 1Deparment of Rheumatology, Cho Ray Hospital, Ho Chi Minh City, Vietnam, 2Department of Rheumatology, Cho Ray Hospital, Ho Chi Minh, Vietnam

    Background/Purpose: Ultrasonography (US) has been increasingly utilized for the assessment of various musculoskeletal conditions. However, the value of this tool in diagnosis of osteoarthritis (OA)…
  • Abstract Number: 0510 • ACR Convergence 2021

    Fibrinogen Modified with Malondialdehyde-Acetaldehyde Adduct (MAA) And/or Citrulline (CIT) Induces Unique Cellular Responses in Human RA Synoviocytes

    Brittany Wordekemper, Nozima Aripova, Michael Duryee, Eric Daubach, Bryant England, James O'Dell, Ted Mikuls and Geoffrey Thiele, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Malondialdehyde (MDA) is produced in response to oxidative stress and is associated with inflammation and disease pathogenesis. MDA can break down and form acetaldehyde…
  • Abstract Number: 0737 • ACR Convergence 2021

    Enhanced Arthrocentesis of the Flexed Knee with Pneumatic Compression

    Sumir Brahmbhatt1, Ahsan Iqbal1, Fatemeh Farshami2, Maheswari Muruganandam3, Jaren Trost4, David Cisneros5, Adnan Kiani3, N. Suzanne Emil3, Sharon Nunez1, William Hayward6, Philip Band7 and Wilmer Sibbitt3, 1UNM, Albuquerque, NM, 2University of New Mexico, Albuquerque, MD, 3University of New Mexico, Albuquerque, NM, 4Optum, Albuquerque, NM, 5University of New Mexico School of Medicine, Albuquerque, NM, 6New Mexico Highlands University, Las Vegas, NM, 7NYU SOM, New York, NY

    Background/Purpose: To explore an alternative to standard extended knee arthrocentesis using pneumatic compression of the flexed knee.Methods: Using a paired sample design, 41 consecutive effusive…
  • « Previous Page
  • 1
  • …
  • 27
  • 28
  • 29
  • 30
  • 31
  • …
  • 63
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology